WebNIMENRIX against the possible risks. If you have any questions about NIMENRIX, ask your doctor, nurse or pharmacist. Keep this leaflet. You may need to read it again. What NIMENRIX is used for NIMENRIX is a vaccine used to help prevent meningococcal disease, caused by four types of Neisseria meningitidis bacteria (types A, C, W and Y). WebNIMENRIX is indicated for active immunisation of individuals from 6 weeks of age against invasive meningococcal diseases caused by . Neisseria meningitidis. groups A, C, W-135 …
Nimenrix - Immunisation Advisory Centre
WebNimenrix is a meningococcal conjugate vaccine to protect against meningococcal groups A, C, W and Y. In New Zealand, Nimenrix is only available as a purchased vaccine for … Web30 May 2024 · Nimenrix Active Ingredient: meningococcal groups A, C, W-135 and Y conjugate vaccine Company: Pfizer Limited See contact details About Medicine … rope access solutions gmbh
ΠΑΡΑΡΤΗΜΑ I ΠΕΡΙΛΗΨΗ ΤΩΝ ΧΑΡΑΚΤΗΡΙΣΤΙΚΩΝ ΤΟΥ …
Web6. Contents of the pack and other information 1. What Nimenrix is and what it is used for What Nimenrix is and what it is used for Nimenrix is a vaccine which helps protect … WebPharmacodynamic properties for further information). Long-term antibody persistence data following vaccination with NIMENRIX are available up to 10 years after vaccination (see Sections 4.4 Special Warnings and Precautions for Use and 5.1 Pharmacodynamic Properties). NIMENRIX may be given as a booster dose to individuals who have previously … WebNIMENRIX PRODUCT INFORMATION NAME OF THE MEDICINE Meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine DESCRIPTION NIMENRIX … rope access uk